Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Jul;254(7):901-6.
doi: 10.1007/s00415-006-0472-9. Epub 2007 Mar 25.

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis

Affiliations
Multicenter Study

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis

Pascual Sanchez-Juan et al. J Neurol. 2007 Jul.

Abstract

Background: The analysis of markers in the cerebrospinal fluid (CSF) is useful in the diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD). However, the time at which the study of these markers is most sensitive remains controversal.

Objective: To assess the influence of time of sampling on the value of CSF tests in the diagnosis of sCJD.

Method: In the framework of a multinational European study, we studied the results of 14-3-3, S100b, neurone specific enolase (NSE) and tau protein in 833 CSF samples from sCJD patients at different stages of disease and in 66 sequentially repeated lumbar punctures (LP).

Results: 14-3-3 and tau protein tended to increase in sensitivity from onset (88%, 81%) to the advanced stage (91%, 90%). This was significant only in the methionine-valine (MV) heterozygous group of patients at codon 129. The absolute levels of S100b (p < 0.05), NSE and tau protein increased in the last stage of disease. High levels of tau protein, NSE and S100b were associated with shorter survival times (p < 0.01). Sixty-six sCJD patients underwent repeated LP. These sCJD patients were younger, had longer disease durations and were more frequently MV at codon 129 (p < 0.001) than the whole group. 14-3-3 sensitivity increased from 64% to 82% in the second LP (p = 0.025) and 88% sCJD patients had at least one positive result.

Conclusions: Sensitivity and absolute levels of CJD markers increased with disease progression and were modulated by the codon 129 genotype. Early negative results should be inter-preted with caution, especially in young patients or those who are MV at codon 129.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Sensitivity of markers for sporadic Creutzfeldt-Jakob disease diagnosis in repeated lumbar punctures (LP) and combined results in both LP. LP = lumbar puncture, + = positive, NSE = neurone specific enolase, and = both LP+, or = either 1st or 2nd+
Fig. 2
Fig. 2
Levels of quantitative markers in repeated lumbar punctures. 1Differences between median levels were not significant. 2THe median S100b levels were different (p = 0.027). *Byk-Sangtec kit

Similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1159/000017095', 'is_inner': False, 'url': 'https://doi.org/10.1159/000017095'}, {'type': 'PubMed', 'value': '10068257', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10068257/'}]}
    2. Beaudry P, Cohen P, Brandel JP, et al. (1999) 14-3-3 protein, neuron-specific enolase, and S100b protein in cerebrospinal fluid of patients with Creutzfeldt- Jakob disease. Dement Geriatr Cogn Disord 10(1):40–6 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO;2-X', 'is_inner': False, 'url': 'https://doi.org/10.1002/1531-8249(20010201)49:2<257::aid-ana48>3.0.co;2-x'}, {'type': 'PubMed', 'value': '11220747', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11220747/'}]}
    2. Brandel JP, Peoc’h K, Beaudry P, et al. (2001) 14-3-3 protein cerebrospinal fluid detection in human growth hormone- treated Creutzfeldt-Jakob disease patients. Ann Neurol 49(2):257–60 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1159/000066174', 'is_inner': False, 'url': 'https://doi.org/10.1159/000066174'}, {'type': 'PubMed', 'value': '12422071', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12422071/'}]}
    2. Giraud P, Biacabe A-G, Chazot G, et al. (2002) Increased detection of 14-3-3 protein in Cerebrospinal fluid in Sporadic Creutzfeldt-Jakob disease during the disease course. Eur Neurol 48:218–221 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0022-1759(97)00050-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0022-1759(97)00050-1'}, {'type': 'PubMed', 'value': '9236913', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9236913/'}]}
    2. Green AJE, Keir G, Thompson EJ (1997) A specific and sensitive ELISA for measuring S100b in the cerebrospinal fluid. J Immmunol Methods 205:35–41 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0009-8981(92)90103-W', 'is_inner': False, 'url': 'https://doi.org/10.1016/0009-8981(92)90103-w'}, {'type': 'PubMed', 'value': '1468153', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1468153/'}]}
    2. Jimi T, Wakayama Y, Shibuya S, et al. (1992) High levels of nervous systemspecific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 211:37–46 - PubMed

Publication types

MeSH terms